AMY SHEFFER: Open Payments
NPI 1689382368 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,812 in 172 payments from 19 companies in 2025. Trend: 2023 $14 · 2024 $2,100 · 2025 $2,812
Food & beverage: $2,805Education: $7
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $511 |
| Regeneron Healthcare Solutions, Inc. | 13 | $367 |
| Janssen Biotech, Inc. | 13 | $342 |
| Galderma Laboratories, L.P. | 18 | $224 |
| Novartis Pharmaceuticals Corporation | 13 | $209 |
| Incyte Corporation | 11 | $180 |
| UCB, Inc. | 17 | $158 |
| MAYNE PHARMA COMMERCIAL LLC | 9 | $158 |
| LEO Pharma Inc. | 12 | $152 |
| Arcutis Biotherapeutics, Inc. | 17 | $144 |
Products named: DUPIXENT, TREMFYA, RINVOQ, SKYRIZI, COSENTYX, NEMLUVIO, OPZELURA, Bimzelx.
Industry payments across OK — which companies pay providers there.
